SBIR Phase I: Streamlining Liquid Biopsy Sample Preparation Through Automated Bisulfite Co — NSF Award to AVANT GENOMICS, LLC (VA,
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of an automated system that dramatically improves the preparation of blood-based cancer tests, known as liquid biopsies. Liquid biopsy has the potential to detect cancer earlier and for therapeut
| Award title | SBIR Phase I: Streamlining Liquid Biopsy Sample Preparation Through Automated Bisulfite Co |
|---|---|
| Award ID | 2528087 |
| Awardee | AVANT GENOMICS, LLC |
| City | CHARLOTTESVILLE |
| State | VA |
| Amount obligated | $305,000 |
| Principal investigator | Rachelle Turiello |
| Program | SBIR Phase I |
| Start date | 10/01/2025 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of an automated system that dramatically improves the preparation of blood-based cancer tests, known as liquid biopsies. Liquid biopsy has the potential to detect cancer earlier and for therapeutic monitoring and minimal residual disease testing by analyzing circulating tumor DNA shed by tumors into the bloodstream. However, the current preparation process is lengthy, expe |
| Source | NSF Awards |
$799/mo
Try NSFGrants →